BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11698418)

  • 1. Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family.
    Bouchon A; Cella M; Grierson HL; Cohen JI; Colonna M
    J Immunol; 2001 Nov; 167(10):5517-21. PubMed ID: 11698418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome.
    Tangye SG; Phillips JH; Lanier LL; Nichols KE
    J Immunol; 2000 Sep; 165(6):2932-6. PubMed ID: 10975798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK cell regulation by SLAM family receptors and SAP-related adapters.
    Veillette A
    Immunol Rev; 2006 Dec; 214():22-34. PubMed ID: 17100873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional requirements for interactions between CD84 and Src homology 2 domain-containing proteins and their contribution to human T cell activation.
    Tangye SG; Nichols KE; Hare NJ; van de Weerdt BC
    J Immunol; 2003 Sep; 171(5):2485-95. PubMed ID: 12928397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytotoxicity receptor CRACC (CS-1) recruits EAT-2 and activates the PI3K and phospholipase Cgamma signaling pathways in human NK cells.
    Tassi I; Colonna M
    J Immunol; 2005 Dec; 175(12):7996-8002. PubMed ID: 16339536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism.
    Nakajima H; Colonna M
    Hum Immunol; 2000 Jan; 61(1):39-43. PubMed ID: 10658976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity.
    Nakajima H; Cella M; Bouchon A; Grierson HL; Lewis J; Duckett CS; Cohen JI; Colonna M
    Eur J Immunol; 2000 Nov; 30(11):3309-18. PubMed ID: 11093147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase.
    Aoukaty A; Tan R
    J Biol Chem; 2002 Apr; 277(15):13331-7. PubMed ID: 11815622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Signaling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicity.
    Henning G; Kraft MS; Derfuss T; Pirzer R; de Saint-Basile G; Aversa G; Fleckenstein B; Meinl E
    Eur J Immunol; 2001 Sep; 31(9):2741-50. PubMed ID: 11536173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defective NK cell activation in X-linked lymphoproliferative disease.
    Benoit L; Wang X; Pabst HF; Dutz J; Tan R
    J Immunol; 2000 Oct; 165(7):3549-53. PubMed ID: 11034354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular and functional characterization of a CS1 (CRACC) splice variant expressed in human NK cells that does not contain immunoreceptor tyrosine-based switch motifs.
    Lee JK; Boles KS; Mathew PA
    Eur J Immunol; 2004 Oct; 34(10):2791-9. PubMed ID: 15368295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic redistribution of the activating 2B4/SAP complex at the cytotoxic NK cell immune synapse.
    Roda-Navarro P; Mittelbrunn M; Ortega M; Howie D; Terhorst C; Sánchez-Madrid F; Fernández-Ruiz E
    J Immunol; 2004 Sep; 173(6):3640-6. PubMed ID: 15356108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The X-linked lymphoproliferative disease gene product SAP is expressed in activated T and NK cells.
    Nagy N; Mattsson K; Maeda A; Liu A; Székely L; Klein E
    Immunol Lett; 2002 Jun; 82(1-2):141-7. PubMed ID: 12008045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular and cellular pathogenesis of X-linked lymphoproliferative disease.
    Nichols KE; Ma CS; Cannons JL; Schwartzberg PL; Tangye SG
    Immunol Rev; 2005 Feb; 203():180-99. PubMed ID: 15661030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WhatSAP - 2B4 sends mixed messages in the absence of SAP.
    Watzl C; Claus M
    Eur J Immunol; 2014 May; 44(5):1281-4. PubMed ID: 24659462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRACC-targeting Fc-fusion protein induces activation of NK cells and DCs and improves T cell immune responses to antigenic targets.
    Aldhamen YA; Rastall DPW; Chen W; Seregin SS; Pereira-Hicks C; Godbehere S; Kaminski NE; Amalfitano A
    Vaccine; 2016 Jun; 34(27):3109-3118. PubMed ID: 27151882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular analysis of NTB-A signaling: a role for EAT-2 in NTB-A-mediated activation of human NK cells.
    Eissmann P; Watzl C
    J Immunol; 2006 Sep; 177(5):3170-7. PubMed ID: 16920955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family.
    Fraser CC; Howie D; Morra M; Qiu Y; Murphy C; Shen Q; Gutierrez-Ramos JC; Coyle A; Kingsbury GA; Terhorst C
    Immunogenetics; 2002 Feb; 53(10-11):843-50. PubMed ID: 11862385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 2B4 (CD244), NTB-A and CRACC (CS1) stimulate cytotoxicity but no proliferation in human NK cells.
    Stark S; Watzl C
    Int Immunol; 2006 Feb; 18(2):241-7. PubMed ID: 16410313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of 2B4 (CD244) activity and regulated SAP expression in human NK cells.
    Endt J; Eissmann P; Hoffmann SC; Meinke S; Giese T; Watzl C
    Eur J Immunol; 2007 Jan; 37(1):193-8. PubMed ID: 17171759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.